Adult onset asynchronous multifocal eosinophilic granuloma of bone: an 11-year follow-up

Dallaudière, B.; Kerger, Joseph; Galant, Christine; Lecouvet, Frédéric

doi:10.1177/2047981614552217

Cited by 1 publication

(1 citation statement)

References 16 publications

(19 reference statements)

Supporting

Mentioning

Contrasting

Order By: Relevance

“…84 The findings consist of multiple areas of bone marrow replacement. 85 As for sarcoidosis, the coexistence of active and healed lesions (partial fatty transformation) may suggest the diagnosis, which however often requires histologic confirmation. WB-MRI appears more sensitive than PET for lesion detection in pediatric forms, but PET might be superior for treatment monitoring.…”

Section: Langerhans Cell Histiocytosismentioning

confidence: 99%

The Increasing Spectrum of Indications of Whole-Body MRI Beyond Oncology: Imaging Answers to Clinical Needs

Lecouvet

Michoux

Toukap

et al. 2015

Semin Musculoskelet Radiol

Self Cite

View full text Add to dashboard Cite

Whole-body coverage using MRI was developed almost 2 decades ago. The first applications focused on the investigation of the skeleton to detect neoplastic disease, mainly metastases from solid cancers, and involvement by multiple myeloma and lymphoma. But the extensive coverage of the whole musculoskeletal system, combined with the exquisite sensitivity of MRI to tissue alteration in relation to different pathologic conditions, mainly inflammation, has led to the identification of a growing number of indications outside oncology. Seronegative rheumatisms, systemic sclerosis, inflammatory diseases involving muscles or fascias, and multifocal osseous, vascular, or neurologic diseases represent currently validated or emerging indications of whole-body MRI (WB-MRI). We first illustrate the most valuable indications of WB-MRI in seronegative rheumatisms that include providing significant diagnostic information in patients with negative or ambiguous MRI of the sacroiliac joints and the lumbar spine, assessing disease activity in advanced (ankylosed) central disease, and evaluating the peripherally dominant forms of spondyloarthropathy. Then we review the increasing indications of WB-MRI in other rheumatologic and nonneoplastic disorders, underline the clinical needs, and illustrate the role of WB-MRI in the positive diagnosis and evaluation of disease burden, therapeutic decisions, and treatment monitoring.

show abstract

Section: Langerhans Cell Histiocytosismentioning

confidence: 99%